AstraZeneca’s add-on pill for the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) won its first approval in Japan, the company
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
